Senior Manager HEOR - Early Pipeline
In the context of a rapidly evolving payer environment, Seagen is an emerging multi-product global oncology company. With a strong commitment to demonstrate product value to the healthcare system, we are building a sophisticated Global Health Economics & Outcomes Research (HEOR) function. The Global HEOR team, within the Global Value Access & Pricing (GVA&P) group, is committed to scientific excellence and the generation of evidence to support value propositions to position Seagen portfolio for continued success.
As a member of the Seagens’ Global HEOR team, the Senior Manager of HEOR will support the strategy and tactical efforts to address value-related drivers and barriers to market access for priority early stage pipeline assets. S/he will assess evidence needs, propose inclusion of clinical trial endpoints and inform on other aspects of clinical trial design, and lead relevant strategic evidence generation, including analyses of data from both primary and secondary sources, and develop the product value propositions and messaging. S/he will support several Seagens’ pipeline compounds. This role will report to the Executive Director, Head of Global HEOR, and will reside within the GVAP (Global Value Access & Pricing) organization. This role will also require cross-functional collaboration across departments such as Medical Affairs, Clinical Development, Marketing, Market Access and multiple other functions.
- Evaluate and synthesize the existing evidence base for the indications of interest, inclusive of unmet need, burden of disease and core evidence for potential comparators in support of the assigned pipeline compounds to inventory existing supporting data and identify data and knowledge gaps
- Collaboratively work with the development team and commercial colleagues to hypothesize the potential value messages that could be planned for the assigned products. Prioritize key value areas of interest and proactively plan for and execute evidence generation to substantiate these value hypotheses
- Drive the design, execution and analysis of HEOR strategies and tactics to support the value propositions of the assigned compounds
- Support efforts to develop evidence-based health economic models to support global strategies and local payer needs. Evaluate and where needed conduct studies to elucidate, burden of illness, budget impact, and cost-effectiveness in disease segments of interest for assigned molecules
- Partner with HEOR Early Pipeline Leaders as they develop and refine early pipeline GVAP support framework in conjunction with early pipeline market access. This can include landscape disease state research, pricing and reimbursement research, patient reported outcome endpoint strategy, early health economic modeling, and collating clinical development study design requirements (endpoint, comparator, measurement strategy) from a value and market access perspective, etc. You will have membership on the early pipeline commercial team as well as the early development teams you support
- Engage with global health economics opinion leaders and external clinical advisors; seek their guidance, validation, and support
- Partner with Medical Affairs and Clinical Development colleagues to prepare conference presentations, manuscripts, and other communications
- Partner with global/regional/country level market access and medical colleagues for early HTA/ payer engagements
- PharmD, Masters, or PhD in Health Economics, Epidemiology, Health Services Research, or other related field. Biological sciences or clinical background necessary
- 3 + years of HEOR and/or market access experience in either global or US roles. Previous experience working in the actuarial, academic, or payer setting may be considered
- Experience developing global value dossiers, health economic models, patient-reported outcome strategy (regulatory and analytic), compound value assessment, and observational research methods required
- Knowledge of the evolving payer landscape and payer evidence requirements in the US and globally
- Oncology experience strongly preferred but not required
Demonstrated ability to:
- Develop meaningful cross-functional relationships, work effectively with colleagues from all parts of the organization, and respond to team needs effectively and efficiently
- Use rigorous logic and analytical methods to solve difficult problems, thrive in ambiguity and act with incomplete information, be self-motivated and advance projects without supervision
- Ability to review clinical and health economic literature, including disease state information, clinical trial design and results, and pharmacoeconomic studies, in order to understand implications for value to payers
- Ability to drive results in a highly fluid, interactive, matrixed environment and build strong, successful cross-functional partnerships
- Demonstrated ability to bring structure to vaguely defined problems, pragmatically scope problem solving approach, and manage execution
- Demonstrated ability to think and plan strategically, identify strategic options and trade-offs, and possesses strong analytical skills
- Excellent oral/written communications skills and interpersonal skills up, down and across the organization
As the leading employer in our industry in the Pacific Northwest, Seagen is proud to offer a competitive total compensation package as well as a comprehensive benefits program designed to support the whole lives of our employees and their families. Benefits include medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more. To learn more about Seagen, please visit www.seattlegenetics.com.
Seagen is an equal opportunity employer. All qualified applications will receive consideration for employment without regard to race, age, gender identity, sexual orientation, color, religion, sex, marital status, national origin, protected veteran status, disability status, or any other status protected by federal, state, or local law.